id	sid	eid	entity	type
ajlm-283	1	1	nokukhanya mdlalose department of virology	ORG
ajlm-283	1	2	national health laboratory service	ORG
ajlm-283	1	3	university of kwazulu-natal	ORG
ajlm-283	1	4	south africa	GPE
ajlm-283	1	5	national health laboratory service	ORG
ajlm-283	1	6	university of kwazulu-natal	ORG
ajlm-283	1	7	south africa	GPE
ajlm-283	1	8	national health laboratory service	ORG
ajlm-283	1	9	university of kwazulu-natal	ORG
ajlm-283	1	10	south africa	GPE
ajlm-283	1	11	south africa	GPE
ajlm-283	2	1	afr j	PERSON
ajlm-283	2	2	2016;5(1	CARDINAL
ajlm-283	3	1	south africa	GPE
ajlm-283	3	2	nokukhanya mdlalose	ORG
ajlm-283	3	3	pravi moodley	PERSON
ajlm-283	3	4	18 nov. 2014	DATE
ajlm-283	3	5	24 nov. 2015	DATE
ajlm-283	3	6	31	CARDINAL
ajlm-283	3	7	mar.	DATE
ajlm-283	4	1	2016	DATE
ajlm-283	4	2	2016	DATE
ajlm-283	8	1	south african	NORP
ajlm-283	9	1	south africa	GPE
ajlm-283	11	1	between july 2011	DATE
ajlm-283	11	2	december 2011	DATE
ajlm-283	11	3	kwazulu	GPE
ajlm-283	11	4	south africa	GPE
ajlm-283	12	1	322	CARDINAL
ajlm-283	14	1	pearson chi-square	PERSON
ajlm-283	14	2	0.05	CARDINAL
ajlm-283	16	1	10%	PERCENT
ajlm-283	17	1	21	CARDINAL
ajlm-283	17	2	161	CARDINAL
ajlm-283	17	3	12	CARDINAL
ajlm-283	17	4	161	CARDINAL
ajlm-283	18	1	13.0%	PERCENT
ajlm-283	18	2	95%	PERCENT
ajlm-283	18	3	ci 6.8–19.9	PERSON
ajlm-283	18	4	7.5%	PERCENT
ajlm-283	18	5	95%	PERCENT
ajlm-283	18	6	2.5–13.7	CARDINAL
ajlm-283	18	7	0.098	CARDINAL
ajlm-283	19	1	10%	PERCENT
ajlm-283	22	1	two billion	CARDINAL
ajlm-283	22	2	more than 350 million	CARDINAL
ajlm-283	22	3	approximately 600 000	CARDINAL
ajlm-283	22	4	annually	DATE
ajlm-283	22	5	south africa	GPE
ajlm-283	22	6	1995.3	CARDINAL
ajlm-283	22	7	south africa	GPE
ajlm-283	22	8	10.4%	PERCENT
ajlm-283	22	9	between 1995	DATE
ajlm-283	22	10	1996.4	CARDINAL
ajlm-283	22	11	limpopo province	GPE
ajlm-283	23	1	5 years	DATE
ajlm-283	24	1	south african	NORP
ajlm-283	24	2	south africa	GPE
ajlm-283	24	3	south africa	GPE
ajlm-283	24	4	3.4%	PERCENT
ajlm-283	24	5	2.9%	PERCENT
ajlm-283	24	6	kwazulu	GPE
ajlm-283	24	7	south africa	GPE
ajlm-283	24	8	5.3%	PERCENT
ajlm-283	24	9	3.1%	PERCENT
ajlm-283	24	10	37.4%	PERCENT
ajlm-283	24	11	2012.12	CARDINAL
ajlm-283	24	12	south african	NORP
ajlm-283	25	1	vardas et al	PERSON
ajlm-283	25	2	10.4%	PERCENT
ajlm-283	25	3	8.9%	PERCENT
ajlm-283	25	4	the 0–6-months age	DATE
ajlm-283	25	5	15.7%	PERCENT
ajlm-283	25	6	the 61–72-months age	DATE
ajlm-283	25	7	between 1995	DATE
ajlm-283	25	8	1996.4	CARDINAL
ajlm-283	25	9	kwazulu	GPE
ajlm-283	25	10	10%	PERCENT
ajlm-283	25	11	18.5%	PERCENT
ajlm-283	25	12	25.1%	PERCENT
ajlm-283	25	13	south african	NORP
ajlm-283	25	14	2011	DATE
ajlm-283	25	15	scotland	GPE
ajlm-283	25	16	guthrie et al.	PERSON
ajlm-283	26	1	1963.15	CARDINAL
ajlm-283	26	2	between 6 weeks	DATE
ajlm-283	26	3	18 months	DATE
ajlm-283	26	4	kwazulu	GPE
ajlm-283	28	1	brec	GPE
ajlm-283	28	2	the university of kwazulu-natal	ORG
ajlm-283	30	1	albert luthuli	PERSON
ajlm-283	30	2	durban	GPE
ajlm-283	30	3	kwazulu	GPE
ajlm-283	30	4	south africa	GPE
ajlm-283	31	1	kwazulu	GPE
ajlm-283	31	2	the national health laboratory service	ORG
ajlm-283	32	1	approximately 9000	CARDINAL
ajlm-283	32	2	®	ORG
ajlm-283	32	3	roche molecular systems, inc.	ORG
ajlm-283	32	4	branchburg	GPE
ajlm-283	32	5	new jersey	GPE
ajlm-283	32	6	united states	GPE
ajlm-283	34	1	18 months	DATE
ajlm-283	35	1	older than 18 months	DATE
ajlm-283	37	1	six-month	DATE
ajlm-283	37	2	july 2011 to	DATE
ajlm-283	37	3	december 2011	DATE
ajlm-283	39	1	29.3%	PERCENT
ajlm-283	39	2	south african	NORP
ajlm-283	39	3	annual	DATE
ajlm-283	39	4	2008.12	CARDINAL
ajlm-283	39	5	322	CARDINAL
ajlm-283	39	6	an estimated	CARDINAL
ajlm-283	39	7	kwazulu-natal21	GPE
ajlm-283	39	8	95%	PERCENT
ajlm-283	39	9	3.5.1	CARDINAL
ajlm-283	39	10	atlanta	GPE
ajlm-283	39	11	georgia	GPE
ajlm-283	39	12	united states	GPE
ajlm-283	42	1	1	CARDINAL
ajlm-283	43	1	first	ORDINAL
ajlm-283	44	1	pres2	ORG
ajlm-283	45	1	1	CARDINAL
ajlm-283	46	1	roche	ORG
ajlm-283	46	2	mannheim	GPE
ajlm-283	46	3	germany	GPE
ajlm-283	47	1	performed24	ORG
ajlm-283	48	1	approximately 50	CARDINAL
ajlm-283	48	2	300	CARDINAL
ajlm-283	48	3	1-ml	QUANTITY
ajlm-283	49	1	10 min at 65 °	TIME
ajlm-283	49	2	95 °	QUANTITY
ajlm-283	49	3	1500	CARDINAL
ajlm-283	49	4	3 minutes	TIME
ajlm-283	50	1	200-µl lysate	FAC
ajlm-283	51	1	9700	CARDINAL
ajlm-283	51	2	carlsbad	GPE
ajlm-283	51	3	california	GPE
ajlm-283	51	4	united states	GPE
ajlm-283	53	1	first	ORDINAL
ajlm-283	53	2	36	CARDINAL
ajlm-283	53	3	first	ORDINAL
ajlm-283	54	1	one	CARDINAL
ajlm-283	54	2	one	CARDINAL
ajlm-283	55	1	first	ORDINAL
ajlm-283	55	2	1:2	CARDINAL
ajlm-283	56	1	36	CARDINAL
ajlm-283	56	2	1%	PERCENT
ajlm-283	57	1	100-bp	QUANTITY
ajlm-283	58	1	mannheim	GPE
ajlm-283	58	2	germany	GPE
ajlm-283	59	1	spss®	ORG
ajlm-283	59	2	22	CARDINAL
ajlm-283	59	3	ibm® inc.	ORG
ajlm-283	59	4	armonk	GPE
ajlm-283	59	5	new york	GPE
ajlm-283	59	6	united states	GPE
ajlm-283	60	1	pearson chi-square	PERSON
ajlm-283	62	1	0.05	CARDINAL
ajlm-283	63	1	spss®	ORG
ajlm-283	64	1	161	CARDINAL
ajlm-283	64	2	161	CARDINAL
ajlm-283	64	3	10%	PERCENT
ajlm-283	64	4	2	CARDINAL
ajlm-283	65	1	21	DATE
ajlm-283	65	2	12	CARDINAL
ajlm-283	66	1	13.0%	PERCENT
ajlm-283	66	2	95%	PERCENT
ajlm-283	66	3	6.8–19.9	PERSON
ajlm-283	66	4	7.5%	PERCENT
ajlm-283	66	5	95%	PERCENT
ajlm-283	66	6	2.5–13.7	CARDINAL
ajlm-283	66	7	0.098	CARDINAL
ajlm-283	67	1	3	CARDINAL
ajlm-283	67	2	0.33	CARDINAL
ajlm-283	68	1	52 weeks	DATE
ajlm-283	68	2	53 weeks	DATE
ajlm-283	68	3	4	CARDINAL
ajlm-283	69	1	0.73	CARDINAL
ajlm-283	70	1	2	CARDINAL
ajlm-283	70	2	kwazulu	GPE
ajlm-283	70	3	south africa	GPE
ajlm-283	70	4	july 2011 to december 2011).†	DATE
ajlm-283	70	5	3	CARDINAL
ajlm-283	70	6	kwazulu	GPE
ajlm-283	70	7	south africa	GPE
ajlm-283	70	8	july 2011 to	DATE
ajlm-283	70	9	december 2011	DATE
ajlm-283	71	1	4	CARDINAL
ajlm-283	71	2	kwazulu	GPE
ajlm-283	71	3	south africa	GPE
ajlm-283	71	4	july 2011 to	DATE
ajlm-283	71	5	december 2011).†	DATE
ajlm-283	71	6	10%	PERCENT
ajlm-283	71	7	kwazulu	GPE
ajlm-283	71	8	south africa	GPE
ajlm-283	72	1	the world health organization	ORG
ajlm-283	72	2	africa	LOC
ajlm-283	72	3	more than 8%.25	CARDINAL
ajlm-283	72	4	african	NORP
ajlm-283	73	1	western africa	GPE
ajlm-283	73	2	85%	PERCENT
ajlm-283	73	3	eastern africa	GPE
ajlm-283	73	4	65% to 85%	PERCENT
ajlm-283	73	5	27-year	DATE
ajlm-283	73	6	1980–2007	CARDINAL
ajlm-283	73	7	africa	LOC
ajlm-283	73	8	around 7%	PERCENT
ajlm-283	73	9	1990	DATE
ajlm-283	73	10	just under 4%	PERCENT
ajlm-283	73	11	2005.2	CARDINAL
ajlm-283	73	12	south africa	GPE
ajlm-283	73	13	south african	NORP
ajlm-283	73	14	counterparts.27	GPE
ajlm-283	73	15	10%	PERCENT
ajlm-283	73	16	18.5%	PERCENT
ajlm-283	73	17	kwazulu	GPE
ajlm-283	73	18	nine-year	DATE
ajlm-283	73	19	kwazulu	GPE
ajlm-283	73	20	12.05%.27	CARDINAL
ajlm-283	73	21	10%	PERCENT
ajlm-283	76	1	africa	LOC
ajlm-283	79	1	almost 10%	PERCENT
ajlm-283	79	2	6 weeks	DATE
ajlm-283	80	1	south african	NORP
ajlm-283	81	1	south african	NORP
ajlm-283	81	2	units.33	GPE
ajlm-283	81	3	24 hours	TIME
ajlm-283	82	1	south african	NORP
ajlm-283	83	1	south africa	GPE
ajlm-283	84	1	kwazulu	GPE
ajlm-283	84	2	south africa	GPE
ajlm-283	87	1	10%	PERCENT
ajlm-283	87	2	kwazulu	GPE
ajlm-283	87	3	south africa	GPE
ajlm-283	88	1	two	CARDINAL
ajlm-283	90	1	the national health laboratory service research trust	ORG
ajlm-283	91	1	n.m.	GPE
ajlm-283	92	1	r.p.	PERSON
ajlm-283	94	1	the national health laboratory service	ORG
ajlm-283	94	2	albert luthuli	PERSON
ajlm-283	94	3	central hospital	ORG
ajlm-283	94	4	university of kwazulu-natal	ORG
ajlm-283	94	5	south africa	GPE
ajlm-283	95	1	d.	NORP
ajlm-283	98	1	ott jj	PERSON
ajlm-283	98	2	stevens ga	PERSON
ajlm-283	98	3	wiersma st.	PERSON
ajlm-283	101	1	http://dx.doi.org/10.1016/j.vaccine.2011.12.116	ORG
ajlm-283	101	2	karim s	PERSON
ajlm-283	101	3	singh	GPE
ajlm-283	101	4	mseleni	LANGUAGE
ajlm-283	101	5	south africa	GPE
ajlm-283	103	1	1989;79(7):893–894	CARDINAL
ajlm-283	103	2	mathai m	PERSON
ajlm-283	103	3	j. preimmunization	PERSON
ajlm-283	103	4	south african	NORP
ajlm-283	105	1	1999;58(2):111–115	CARDINAL
ajlm-283	106	1	burnett rj	PERSON
ajlm-283	106	2	hlungwani np	PERSON
ajlm-283	106	3	sibara mm	PERSON
ajlm-283	106	4	mphahlele mj	PERSON
ajlm-283	107	1	the first five years	DATE
ajlm-283	107	2	south africa	GPE
ajlm-283	107	3	5-year-olds	DATE
ajlm-283	109	1	2001;19(28-29):3919–3926	CARDINAL
ajlm-283	110	1	http://dx.doi.org/10.1016/s0264-410x(01)00120-7 simani oe	PERSON
ajlm-283	110	2	leroux-roels g	ORG
ajlm-283	110	3	françois g	PERSON
ajlm-283	110	4	burnett rj	PERSON
ajlm-283	110	5	meheus	PERSON
ajlm-283	110	6	mphahlele mj	PERSON
ajlm-283	110	7	2-year-old	DATE
ajlm-283	110	8	south african	NORP
ajlm-283	112	1	2009;27(1):146–151	CARDINAL
ajlm-283	113	1	hollander hh	PERSON
ajlm-283	113	2	ae	ORG
ajlm-283	113	3	lavine je	PERSON
ajlm-283	115	1	ann intern med	PERSON
ajlm-283	116	1	1992;117(10):837–838	CARDINAL
ajlm-283	117	1	http://dx.doi.org/10.7326/0003-4819-117-10-837 horvath j	PERSON
ajlm-283	118	1	clin infect dis	ORG
ajlm-283	120	1	burnett rj	PERSON
ajlm-283	120	2	ngobeni jm	PERSON
ajlm-283	120	3	françois g	PERSON
ajlm-283	120	4	leroux-roels g	ORG
ajlm-283	120	5	meheus	PERSON
ajlm-283	120	6	south african	NORP
ajlm-283	122	1	2007;18(3):152–156	CARDINAL
ajlm-283	122	2	http://dx.doi.org/10.1258/095646207780132523 burnett rj	PERSON
ajlm-283	122	3	françois g	PERSON
ajlm-283	122	4	kew mc	PERSON
ajlm-283	122	5	leroux-roels g	PERSON
ajlm-283	122	6	meheus	PERSON
ajlm-283	123	1	africa	LOC
ajlm-283	125	1	2005;25(2):201–213	CARDINAL
ajlm-283	126	1	andersson mi	PERSON
ajlm-283	126	2	maponga tg	PERSON
ajlm-283	126	3	ijaz s	PERSON
ajlm-283	126	4	barnes j	PERSON
ajlm-283	126	5	theron gb	PERSON
ajlm-283	126	6	meredith sa	PERSON
ajlm-283	127	1	south africa	GPE
ajlm-283	129	1	2013;31(47):5579–5584	CARDINAL
ajlm-283	130	1	2008	DATE
ajlm-283	130	2	national antenatal sentinel hiv & syphilis	ORG
ajlm-283	130	3	south africa	GPE
ajlm-283	131	1	pretoria	GPE
ajlm-283	131	2	national department of health	ORG
ajlm-283	131	3	2009	DATE
ajlm-283	132	1	abdool karim ss	PERSON
ajlm-283	132	2	fouche a.	PERSON
ajlm-283	132	3	kwazulu	GPE
ajlm-283	132	4	south africa	GPE
ajlm-283	134	1	1988;17(1):168–173	CARDINAL
ajlm-283	135	1	http://dx.doi.org/10.1093/ije/17.1.168 chotun n	ORG
ajlm-283	135	2	nel e	PERSON
ajlm-283	135	3	preiser w	PERSON
ajlm-283	135	4	andersson mi	PERSON
ajlm-283	135	5	south africa	GPE
ajlm-283	137	1	2015;33(36	CARDINAL
ajlm-283	137	2	4618–4622	CARDINAL
ajlm-283	138	1	susi a.	PERSON
ajlm-283	140	1	1963;32:338–343	CARDINAL
ajlm-283	141	1	neumann p	ORG
ajlm-283	141	2	schechter mt	PERSON
ajlm-283	141	3	1	CARDINAL
ajlm-283	142	1	j clin microbiol	PERSON
ajlm-283	143	1	1991;29(4):667–671	CARDINAL
ajlm-283	144	1	salas t	GPE
ajlm-283	144	2	gill mj	PERSON
ajlm-283	144	3	sy ct	PERSON
ajlm-283	145	1	j clin microbiol	PERSON
ajlm-283	146	1	1992;30(12):3039–3042	CARDINAL
ajlm-283	147	1	sherman gg	PERSON
ajlm-283	147	2	stevens g	PERSON
ajlm-283	147	3	jones sa	PERSON
ajlm-283	147	4	horsfield p	PERSON
ajlm-283	147	5	stevens ws	PERSON
ajlm-283	149	1	j acquir	PERSON
ajlm-283	150	1	2005;38(5):615–617	CARDINAL
ajlm-283	151	1	maldonado-rodriguez	PERSON
ajlm-283	151	2	rojas-montes o	ORG
ajlm-283	151	3	ruiz-tachiquin m	PERSON
ajlm-283	151	4	torres-ibarra	PERSON
ajlm-283	151	5	cano-dominguez	ORG
ajlm-283	152	1	virol j. 2009;6(1):1	PERSON
ajlm-283	152	2	de oliveira jc	PERSON
ajlm-283	152	3	cruz hm	PERSON
ajlm-283	152	4	yoshida cf	PERSON
ajlm-283	152	5	lampe e	GPE
ajlm-283	155	1	2011;83(9):1522–1529	CARDINAL
ajlm-283	156	1	south africa	GPE
ajlm-283	157	1	mid-year	DATE
ajlm-283	157	2	2010	DATE
ajlm-283	157	3	pretoria: statistics south africa	ORG
ajlm-283	157	4	2010	DATE
ajlm-283	158	1	bowyer s. molecular characterization	PERSON
ajlm-283	158	2	south africa	GPE
ajlm-283	160	1	johannesburg: university of the witwatersrand	ORG
ajlm-283	160	2	2001	DATE
ajlm-283	161	1	bowyer sm	PERSON
ajlm-283	161	2	van staden l	PERSON
ajlm-283	161	3	kew mc	PERSON
ajlm-283	162	1	south africa	GPE
ajlm-283	163	1	gen virol	PERSON
ajlm-283	164	1	1997;78(pt 7):1719–1729	CARDINAL
ajlm-283	165	1	1997/07/01	DATE
ajlm-283	166	1	patton jc	PERSON
ajlm-283	166	2	stevens ws	PERSON
ajlm-283	166	3	sherman gg	PERSON
ajlm-283	167	1	1	CARDINAL
ajlm-283	168	1	clin vaccine immunol	ORG
ajlm-283	169	1	2007;14(2):201–203	CARDINAL
ajlm-283	169	2	d.	NORP
ajlm-283	170	1	j clin virol	PERSON
ajlm-283	171	1	2005;34	CARDINAL
ajlm-283	172	1	kew mc	PERSON
ajlm-283	172	2	africa	LOC
ajlm-283	174	1	2007;37(s1):s9	CARDINAL
ajlm-283	175	1	maskew m	PERSON
ajlm-283	175	2	macphail p	ORG
ajlm-283	176	1	south african	NORP
ajlm-283	178	1	simard ep	PERSON
ajlm-283	178	2	bell bp	ORG
ajlm-283	180	1	epidemiol rev	PERSON
ajlm-283	182	1	shiraki k.	PERSON
ajlm-283	184	1	j gastroenterol hepatol	PERSON
ajlm-283	185	1	2000;15(s2):e11	ORG
ajlm-283	186	1	nv	ORG
ajlm-283	189	1	j. 2014;104(4):307–309	PERSON
ajlm-283	189	2	tran tt	PERSON
ajlm-283	189	3	martin p. hepatitis	PERSON
ajlm-283	191	1	clin liver dis	PERSON
ajlm-283	192	1	beasley rp	PERSON
ajlm-283	192	2	hwang ly	PERSON
ajlm-283	192	3	lee gc	PERSON
ajlm-283	192	4	lan cc	PERSON
ajlm-283	192	5	roan ch	PERSON
ajlm-283	192	6	huang fy	PERSON
ajlm-283	193	1	lancet	ORG
ajlm-283	195	1	http://dx.doi.org/10.1016/s0140-6736(83)90624-4 hoffmann cj	PERSON
ajlm-283	195	2	mashabela	PERSON
ajlm-283	195	3	cohn s	PERSON
ajlm-283	195	4	hoffmann jd	PERSON
ajlm-283	196	1	south africa	GPE
ajlm-283	198	1	2014;17:18871	CARDINAL
ajlm-283	200	1	liang x	PERSON
ajlm-283	200	2	bi s	PERSON
ajlm-283	200	3	yang w	PERSON
ajlm-283	200	4	wang l	PERSON
ajlm-283	200	5	cui g, cui f	PERSON
ajlm-283	201	1	china	GPE
ajlm-283	204	1	http://dx.doi.org/10.1016/j.vaccine.2013.08.012	CARDINAL